Immunoprecise Antibodies Ltd expected to post a loss of 9 cents a share - Earnings Preview

Reuters
2024-12-06
<a href="https://laohu8.com/S/IPA">Immunoprecise Antibodies Ltd</a> <ipa.oq> expected to post a loss of 9 cents a share - Earnings Preview </ipa.oq>
  • Immunoprecise Antibodies Ltd IPA.OQ IPA.O is expected to show a rise in quarterly revenue when it reports results on December 10 for the period ending October 31 2024

  • The Victoria British Columbia-based company is expected to report a 4.7% increase in revenue to C$6.439 million from C$6.15 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Immunoprecise Antibodies Ltd is for a loss of 9 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Immunoprecise Antibodies Ltd is $6.00​, above​ its last closing price of $0.37. ​​​

This summary was machine generated December 6 at 13:34 GMT. All figures in Canadian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10